Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 5, 2008, Pages 1840-1842

  Roberts, Lindi ^a   Egan, Timothy J ^b   Joiner, Keith A ^c   Hoppe, Heinrich C ^a,d  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d DSI CSIR Nanotechnology Innovation Centre   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; CHLOROQUINE; HALOFANTRINE; HEME; HEMOGLOBIN; HORSERADISH PEROXIDASE; MEFLOQUINE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PROTEINASE INHIBITOR; QUININE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOCYTOSIS; HEMOGLOBIN DETERMINATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN TRANSPORT; TRANSPORT VESICLE;

AMODIAQUINE; ANIMALS; ANTIMALARIALS; BLOTTING, WESTERN; CHLOROQUINE; ENDOCYTOSIS; ERYTHROCYTES; HEMOGLOBINS; HUMANS; MEFLOQUINE; PEROXIDASE; PHENANTHRENES; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTOZOAN PROTEINS; QUINOLINES;

EID: 42949158177     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01478-07     Document Type: Article

References (23)

1. Bray, P. G., S. A. Ward, and P. M. O'Neill. 2005. Quinolines and artemisinin: chemistry, biology and history. Curr. Top. Microbiol. Immunol. 295:3-38.
2. Chen, L. H., M. E. Wilson, and P. Schlagenhauf. 2007. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 297:2251-2263.
3. Chevli, R., and C. D. Fitch. 1982. The antimalarial drug mefloquine binds to membrane phospholipids. Antimicrob. Agents Chemother. 21:581-586.
4. Chou, A. C., and C. D. Fitch. 1993. Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem. Biophys. Res. Commun. 195:422-427.
5. Dorn, A., S. R. Vippagunta, H. Matile, C. Jaquet, J. L. Vennerstrom, and R. G. Ridley. 1998. An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem. Pharmacol. 55:727-736.
6. Egan, T. J., J. M. Combrinck, J. Egan, G. R. Hearne, H. M. Marques, S. Ntenteni, B. T. Sewell, P. J. Smith, D. Taylor, D. A. Van Schalkwyk, and J. C. Walden. 2002. Fate of haem iron in the malaria parasite Plasmodium falciparum. Biochem. J. 365:343-347.
7. Egan, T. J., and H. M. T. Marques. 1999. The role of haem in the activity of chloroquine and related antimalarial drugs. Coord. Chem. Rev. 192:493-517.
8. Egan, T. J., and K. K. Ncokazi. 2005. Quinoline antimalarials decrease the rate of β-hematin formation. J. Inorg. Biochem. 99:1532-1539.
9. Egan, T. J., D. C. Ross, and P. A. Adams. 1994. Quinoline antimalarial drugs inhibit spontaneous formation of β-haematin (malaria pigment). FEBS Lett. 352:54-57.
10. Famin, O., and H. Ginsburg. 2002. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochem. Pharmacol. 63:393-398.
11. Foley, M., and L. Tilley. 1998. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. Pharmacol. Ther. 79:55-87.
12. Francis, S. E., D. J. Sullivan, and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
13. Ginsburg, H., and R. A. Demel. 1984. Interactions of hemin, antimalarial drugs and hemin-antimalarial complexes with phospholipid monolayers. Chem. Phys. Lipids 35:331-347.
14. Hawley, S. R., P. G. Bray, M. Mungthin, J. D. Atkinson, P. M. O'Neill, and S. Ward. 1998. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 42:682-686.
15. Hoppe, H. C., D. A. van Schalkwyk, U. I. M. Wiehart, S. A. Meredith, J. Egan, and B. W. Weber. 2004. Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum. Antimicrob. Agents Chemother. 48:2370-2378.
16. Mishra, S. K., S. Mohanty, A. Mohanty, and B. S. Das. 2006. Management of severe and complicated malaria. J. Postgrad. Med. 52:281-287.
17. Montgomery, R. R., P. Webster, and I. Mellman. 1991. Accumulation of indigestible substances reduces fusion competence of macrophage lysosomes. J. Immunol. 147:3087-3095.
18. Mungthin, M., P. G. Bray, R. G. Ridley, and S. A. Ward. 1998. Central role of hemoglobin degradation in mechanisms of action of 4-aminoquinolines, quinoline methanols, and phenanthrene methanols. Antimicrob. Agents Chemother. 42:2973-2977.
19. Sirima, S. B., and A. Gansané. 2007. Artesunate-amodiaquine for the treatment of uncomplicated malaria. Expert Opin. Investig. Drugs 16:1079-1085.
20. Smythe, W. A., K. A. Joiner, and H. C. Hoppe. 2008. Actin is required for endocytic trafficking in the malaria parasite Plasmodium falciparum. Cell. Microbiol. 10:452-464.
21. Sullivan, D. J. 2002. Theories on malarial pigment formation and quinoline action. Int. J. Parasitol. 32:1645-1653.
22. Zhang, J., M. Krugliak, and H. Ginsburg. 1999. The fate of ferriprotorphyrin IX in malaria infected erythrocytes in conjunction with the mode of action of antimalarial drugs. Mol. Biochem. Parasitol. 99:129-141.
23. Zidovetzki, R., I. W. Sherman, A. Atiya, and H. De Boeck. 1989. A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with dipalmitoylphosphatidylcholine bilayers. Mol. Biochem. Parasitol. 35:199-207.